EMA recommends orphan designation for AML drugMay 25, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drug receives breakthrough designation for relapsed/refractory AMLMay 19, 2017Leukemia, Myelodysplasia, TransplantationAML
Antibody shows potential for treating AML, B-ALLMay 16, 2017Leukemia, Myelodysplasia, TransplantationAMLALL
Novel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Formaldehyde probably doesn’t cause leukemia, team saysMay 3, 2017Leukemia, Myelodysplasia, TransplantationAML
Company withdraws MAA for vosaroxin in AMLMay 3, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drug receives orphan designation for AMLMay 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA approves midostaurin to treat FLT3+ AML, advanced SMMay 1, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Role of TET2 in hematologic malignanciesApril 26, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Second cancers take greater toll on younger patientsApril 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Study correlates genetic mutations with AML subgroupsApril 19, 2017Leukemia, Myelodysplasia, TransplantationAML
TKI shows promise in preclinical study of AMLApril 15, 2017Leukemia, Myelodysplasia, TransplantationAML
Study reveals global inequalities in childhood leukemia survivalApril 12, 2017Leukemia, Myelodysplasia, TransplantationPediatricsAMLALL
Drug receives orphan designation for AMLMarch 29, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
